Showing results (51-60 of 116) with videos related to
Sort By:
Pageof 12
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 26, 2024
Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advancesTingrui Zhang, Zongguang Tai, Fengze Miao, et al.Biofilm|February 1, 2024
Staphylococcus aureus biofilm: Formulation, regulatory, and emerging natural products-derived therapeuticsXiying Wu, Huan Wang, Juan Xiong, et al.Acta Pharmaceutica Sinica. B|July 15, 2026
Engineering an immuno-nanoprodrug: Photo-controlled pyroptosis synergizing with acid-activatable immunometabolic blockade for potent cancer immunotherapyZhiliang Yu, Hong Wang, Qin Yu, et al.Molecular Pharmaceutics|October 14, 2021
Immunotherapy Strategy Targeting Programmed Cell Death Ligand 1 and CD73 with Macrophage-Derived Mimetic Nanovesicles to Treat Bladder CancerQidong Zhou, Weihong Ding, Zhiyu Qian, et al.Medcomm|April 22, 2025
Alopecia Areata: Pathogenesis, Diagnosis, and TherapiesTianyou Ma, Tingrui Zhang, Fengze Miao, et al.Journal of Advanced Research|September 24, 2023
Nanomedicine-induced programmed cell death enhances tumor immunotherapyJiaye Lu, Zongguang Tai, Junchao Wu, et al.Pharmaceutics|May 27, 2023
Pickering Emulsions Enhance Oral Bioavailability of Curcumin Nanocrystals: The Effect of Oil TypesYuze Sheng, Qin Yu, Yanping Huang, et al.Pharmaceutical Research|March 30, 2022
Converting Tretinoin into Ionic Liquids for Improving Aqueous Solubility and Permeability across SkinXiying Wu, Jingjing Xuan, Qin Yu, et al.International Journal of Pharmaceutics|November 27, 2024
Enhanced transdermal delivery of insulin by choline-based ionic liquidsYang Li, Qin Yu, Yi Lu, et al.Acta Pharmaceutica Sinica. B|July 19, 2024
Julolidinyl aza-BODIPYs as NIR-II fluorophores for the bioimaging of nanocarriersChang Liu, Yifan Cai, Zichen Zhang, et al.Pageof 12